Exane Derivatives’s Vanguard FTSE Europe ETF VGK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,566
Closed -$658K 978
2022
Q1
$658K Buy
+10,566
New +$678K 0.19% 145
2021
Q4
Sell
-8,585
Closed -$563K 1030
2021
Q3
$563K Buy
8,585
+1,580
+23% +$108K 0.14% 163
2021
Q2
$476K Sell
7,005
-4,420
-39% -$298K 0.11% 190
2021
Q1
$720K Buy
11,425
+2,040
+22% +$127K 0.21% 109
2020
Q4
$565K Buy
+9,385
New +$528K 0.17% 132

Other funds holding VGK

Exane Derivatives's VGK Position: Q2 2022 in Review

Exane Derivatives sold out of Vanguard FTSE Europe ETF (VGK) in Q2 2022, closing a stake of 10,566 shares — an estimated $658K sold.

Exane Derivatives first reported a position in VGK in Q4 2020 and held it in 5 quarters. The position peaked at $720K in Q1 2021. 594 funds tracked by Wall St. Rank hold VGK as of Q2 2022.

  • Exane Derivatives reported no remaining Vanguard FTSE Europe ETF position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 10,566 Vanguard FTSE Europe ETF shares in Q2 2022, an estimated $658K.
  • Exane Derivatives first reported a position in Vanguard FTSE Europe ETF in Q4 2020 and held it in 5 quarters.
  • Exane Derivatives's Vanguard FTSE Europe ETF position peaked at $720K in Q1 2021.
  • 594 funds tracked by Wall St. Rank held Vanguard FTSE Europe ETF as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.